The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Levetiracetam
levetiracetam · LEVETIRACETAM 100 mg/mL · Injection, Solution, Concentrate · Intravenous · TAGI Pharma, Inc.
NDC 51224-0013-10 · 10 VIAL, SINGLE-USE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-USE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Medicaid spend (2025)
$358
56 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $52.15 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA209781
- TE code
- AP
- Approval date
- Mar 20, 2018
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of levetiracetam (Injection, Solution, Concentrate)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| XGen Pharmaceuticals DJB, Inc. | LEVETIRACETAM 500 mg/5mL | Sep 3, 2026 | Sep 3, 2026 |
| Aryeh Pharma corp | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Baxter Healthcare Corporation | LEVETIRACETAM 100 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Novadoz Pharmaceuticals LLC | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Italia S.p.A. | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Precision Dose, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| UCB, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| TAGI Pharma, Inc. | LEVETIRACETAM 100 mg/mL | Jul 15, 2026 | Aug 5, 2026 |
| Sagent Pharmaceuticals | LEVETIRACETAM 500 mg/5mL | Jul 15, 2026 | Jul 29, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Levetiracetam — NDC 51224-0013-10," retrieved September 3, 2026, https://drugdashboards.com/drug/51224001310.
Free to cite with attribution — see how the data is put together.